AGP Picks
View all

Healthcare Focus Montserrat: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Focus Montserrat.

Press releases published on July 13, 2026

Sienna Senior Living Named One of Canada's Best Companies by TIME and Statista for Second Consecutive Year
BrewDog Waterloo to Host England's Biggest Pub Watch Party for Blockbuster Semifinal
Acentra Health Appoints Michael Kingston as Chief Digital & Information Officer to Lead Technology and AI Innovation
Aegis Treatment Centers Opens New Medication Unit in Yreka, Opening Up Access to Opioid Treatment in Siskiyou County
Artelo Biosciences Announces Positive Results with ART27.13 in a Nonclinical Model of Paclitaxel-Induced Peripheral Neuropathy
Bavarian Nordics chikungunyavaccine indsendt til myndighedsgodkendelse i Brasilien
Bavarian Nordic’s Chikungunya Vaccine Submitted for Regulatory Approval in Brazil
Omada Health to Participate in Canaccord Genuity’s 46th Annual Growth Conference
Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal Cancer Trial
Cadrenal Therapeutics’ Late-Breaking Phase 2 Data Demonstrate Greater Than 25% Reduction in Thrombotic Events in HIT for First-in-Class 12-LOX Inhibitor CAD-1005 at ISTH 2026 Congress
Fortrea Announces Date for Second Quarter 2026 Financial Results and Conference Call
First patient treated in Phase 2 A-TANGO trial for acute-on-chronic liver failure
Enovis™ Companion Animal Health Launches CT-RevitL™, the Next-Generation Laser Therapy System for Veterinary Care
Cue Biopharma Appoints Dominic Borie, M.D., Ph.D., as Chief Medical Officer and Head of Research & Development
Pliant Therapeutics Names Flavia Borellini, Ph.D. and Robert Iannone, M.D., M.S.C.E. to Board of Directors
Solésence Brings Patent-Backed Skin Health Innovation to Hair and Scalp
Clearmind Shares Promising Real-World Insights from Ongoing CMND-100 First-in-Human Trial
Voyager Demonstrates Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 6-Month GLP Toxicology Study; Initiation of Clinical Trial in Alzheimer’s Disease Expected H2 2026
Aligos Therapeutics Announces the Completion of Enrollment in the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium Under Development for the Treatment of Chronic HBV Infection
Madrigal Pharmaceuticals Announces Three New Resmetirom Patents, Strengthening IP Portfolio

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthcare Focus Montserrat

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.